The autophagy sensor ITPR1 protects renal carcinoma cells from NK-mediated killing

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Clear cell renal cell carcinoma (ccRCC) is characterized by VHL gene mutations, leading to hypoxia-inducible factor (HIF) activation and a distinct transcriptional signature.
• VHL inactivation promotes ccRCC development and progression by stabilizing HIFs, which drive tumor adaptation to hypoxic conditions.

Purpose of the Study:

• To investigate the mechanism by which VHL mutations confer resistance to Natural Killer (NK) cell-mediated lysis in ccRCC.
• To identify novel molecular targets that regulate NK cell activity and tumor cell interactions in ccRCC.

Main Methods:

• Analysis of VHL-mutated ccRCC samples and cell lines.
• Investigation of EPAS1/HIF-2α stabilization and its role in ccRCC immune evasion.
• Identification and functional characterization of ITPR1 as a downstream target of EPAS1.
• Assessment of ITPR1's role in regulating autophagy and NK cell-mediated killing.

Main Results:

• VHL mutation in ccRCC leads to EPAS1/HIF-2α stabilization, contributing to resistance against NK cell lysis.
• ITPR1 was identified as a direct target of EPAS1.
• ITPR1 regulates NK cell-mediated killing by modulating autophagy in target cells, triggered by NK cell signals.

Conclusions:

• EPAS1/HIF-2α stabilization is a key mechanism for ccRCC immune evasion of NK cells.
• ITPR1 acts as a critical regulator of NK cell cytotoxicity through autophagy modulation.
• Targeting EPAS1 or ITPR1 presents a potential therapeutic strategy to enhance NK cell-based immunotherapy for RCC and other solid tumors.